Discovery of Novel Self-Antigens in IgG4-Related Disease Using Computational Modeling and Human Proteome Screening
ISEF · 2025 Translational Medical Science
Overview
Autoimmune diseases affect millions worldwide, yet many are difficult to diagnose due to biological complexity and variability across patients. I developed a computational pipeline to address autoimmune heterogeneity, enabling the discovery of novel self-antigens in IgG4-related disease (IgG4-RD)—an immune-mediated disorder characterized by tumor-like lesions, fibrosis, and organ dysfunction, and lacking a defined autoimmune signature. While prior research shows that IgG4-RD patients harbor plasmablasts that recognize self-antigens, no consistent disease-specific autoantibody response has been identified. I hypothesized that proteome-wide computational screening could uncover self-antigens that define and sub-cluster IgG4-RD patients. To test this, I analyzed HuProt microarray data previously collected from 30 patients with IgG4-RD and 30 patients with Systemic Sclerosis (SSc, positive control). Using R, I used three machine learning models—LASSO regression, linear and generalized linear mixed models (LMM/GLMM), and SLIDE—to identify differentially bound proteins. Each model performed with high prediction accuracy (AUC > 0.9), and their intersection revealed seven consistently reactive autoantigens. Two, POLR3K and TOP1MT, were known targets in SSc. DDX3Y and LIMS1 emerged as strong candidates for IgG4-RD-specific autoantigens, with literature suggesting roles in immune regulation and IgG subclass expression. Gene Ontology analysis confirmed biological relevance, highlighting functions like RNA Polymerase III activity. This work advances our understanding of IgG4-RD pathophysiology and establishes a scalable framework for autoantigen discovery. It opens the door to personalized diagnostics in immunology by enabling high-resolution profiling of autoreactivity.
Competition history
- ISEF 2025
Resources
Related projects
ISEF · 2023
Advancing Autoimmune Disease Treatment With AI-Assisted Gene Expression Analysis
ISEF · 2021
Formulating a Gene Signature for Diagnosis of Autoimmune and Infectious Diseases
ISEF · 2025
Design and in silico Validation of a Novel Fc-fusion Protein for the Treatment of Myasthenia Gravis
ISEF · 2019
The Identification and Characterization of PRDM1 Co-factors in HEK Cells
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair